Pathstone Holdings, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2011612 ENGLEWOOD, NJ

Position in VRTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$19,764,751

-$910,277 QoQ

Shares Held

44,262

-2.9% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 48.26261804708328.ToString("F0")% Shared 0.5467443857033122.ToString("F0")% None 51.190637567213415.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pathstone Holdings, LLC holds $81,066,919 across 49 Biotechnology names. VRTX ranks #1 (24.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	44,262	$19,764,751
2	REGN	Regeneron Pharmaceuticals, Inc.	15,912	$12,294,246
3	INSM	INSMED Inc	27,249	$4,455,756
4	PTGX	Protagonist Therapeutics, Inc	28,252	$2,977,760
5	CYTK	Cytokinetics Inc	44,516	$2,934,049
6	MDGL	Madrigal Pharmaceuticals, Inc.	5,457	$2,856,575
7	JAZZ	Jazz Pharmaceuticals plc	13,947	$2,636,679
8	IONS	Ionis Pharmaceuticals Inc	32,835	$2,465,579

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,764,751	44,262	-2.9%	Shares	Sole	2026-05-11
2025-12-31	$20,675,028	45,604	+20.4%	Shares	Defined	2026-02-13
2025-09-30	$14,834,930	37,879	+4.0%	Shares	Sole	2025-11-13
2025-06-30	$16,219,971	36,433	-3.8%	Shares	Other	2025-08-12
2025-03-31	$18,362,071	37,874	+1.4%	Shares	Other	2025-05-15
2024-12-31	$15,042,052	37,353	-8.1%	Shares	Defined	2025-02-14
2024-09-30	$18,906,896	40,653	+5.5%	Shares	Sole	2024-11-07
2024-06-30	$18,064,937	38,541	+4.2%	Shares	Other	2024-08-14
2024-03-31	$15,467,622	37,003	+13.7%	Shares	Defined	2024-05-13
2023-12-31	$13,236,537	32,531	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.